Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06776224

Visual (Path)Ways in Multiple Sclerosis - Part II

Evaluation of Neuroaxonal Loss Outside of Any Inflammation in Multiple Sclerosis by a Multimodal Study of the Visual Pathways Model

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
64 (estimated)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Multiple sclerosis (MS) is an inflammatory demyelinating and degenerative disease of the central nervous system. The mechanisms of neuro-axonal loss remain incompletely elucidated. An acute demyelinating lesion will produce both immediate and delayed axonal loss. Immediate axonal loss is linked to the occurrence of axonal transection. Delayed axonal loss is the cause of axonal degeneration in progressive MS. Visual impairment is common in the disease (vision, oculomotricity, cognition). Through a longitudinal multimodal analysis of visual pathways, we would like to investigate physiopathological mechanisms leading to neurodegenerative process and visual impairment.

Conditions

Interventions

TypeNameDescription
OTHERMeasurement of retinal vascular density and visual cognitionDuring the same visit, we will perform OCT-angiography (10 minutes) and evaluate visual cognition with an eye-tracker (20 minutes)

Timeline

Start date
2025-01-24
Primary completion
2026-04-24
Completion
2026-04-24
First posted
2025-01-15
Last updated
2025-01-31

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06776224. Inclusion in this directory is not an endorsement.